Business
AI summaryCharles River Laboratories provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. Its Research Models and Services segment produces rodents and purpose-bred rats and mice for researchers, along with genetically engineered models, insourcing solutions, research animal diagnostics, and cell therapy development. The Discovery and Safety Assessment segment offers in vitro and in vivo services for discovering, developing, and safety testing novel drugs, compounds, oligonucleotides, and biotherapeutics.
Discovery And Safety Assessment 60% · Research Models And Services 21% · Manufacturing Support 19%
business segments · FY2025 (ended Dec 2025) · share of tagged segment revenue (10-K XBRL, as filed)
